EBRO 2017
ACT studies
• ~1/3 rd GBM are EGFR+ve • EGFR+ve GBM have a worse prognosis • We can target EGFR
Let’s do a trial !
Made with FlippingBook Learn more on our blog
ACT studies
• ~1/3 rd GBM are EGFR+ve • EGFR+ve GBM have a worse prognosis • We can target EGFR
Let’s do a trial !
Made with FlippingBook Learn more on our blog